Funds for fresh acquisitions
Mechelen – Belgian service and drug development specialist Galapagos NV has raised EUR28.7m through the sale of 2.4 million shares at a 12 per share in a private placement. The share price represents an 8 % discount to Galapagos’ close of EUR 13.10 on the day before the placement was proposed. Galapagos said the proceeds will be used to finance possible future acquisitions. ABN AMRO and KBC Securities acted as joint global coordinators and bookrunners.